Drug-delivery microcapsules tagged with zirconium-89 can be tracked by PET imaging

January 20, 2021

BIRMINGHAM, Ala. - University of Alabama at Birmingham polymer and radionuclide chemists report what they say "may represent a major step forward in microcapsule drug delivery systems."

The UAB microcapsules -- labeled with radioactive zirconium-89 -- are the first example of hollow polymer capsules capable of long-term, multiday positron emission tomography, or PET, imaging in vivo. In previous work, UAB researchers showed that the hollow capsules could be filled with a potent dose of the cancer drug doxorubicin, which could then be released by therapeutic ultrasound that ruptures the microcapsules.

PET imaging with zirconium-89 -- which has a half-life of 3.3 days -- allowed the capsules to be traced in test mice up to seven days. The major step forward in the current research was covalent incorporation of a zirconium chelator, deferoxamine or DFO, into the layers of the microcapsules. This increased the tight binding of the positron emitter zirconium-89 onto the microcapsule wall.

"The produced systems represent an example of an advanced theranostic agent with the possibility to combine controlled drug delivery with stable PET imaging capabilities," said Eugenia Kharlampieva, Ph.D., and Suzanne Lapi, Ph.D., co-senior authors. "We believe this system also provides the groundwork for a universal drug delivery carrier that can be coupled with advanced targeted treatments, such as patient-tailored gene therapeutics, and can lead to the advancement of human health through molecularly targeted, image-guided precision drug delivery."

This drug delivery system -- after surface modifications to boost targeting capabilities -- could offer a non-invasive alternative to cancer surgery or systemic chemotherapy for solid tumors. The term theranostic, a portmanteau of the words therapy and diagnostic, refers to nanoparticles or microcapsules that can double as diagnostic imaging agents and as therapeutic drug-delivery carriers.

The relative paucity of zirconium-89 functionalized particles, Kharlampieva and Lapi suggest, may be due to both the scarcity of laboratories able to work with this isotope and the challenges associated with its stable incorporation into a polymeric drug carrier. At UAB, Kharlampieva is a professor in the UAB College of Arts and Sciences Department of Chemistry and a co-director of the UAB Center for Nanomaterials and Biointegration. Her polymer chemistry lab has pioneered research into hollow microcapsules that are built with alternating layers of biocompatible tannic acid and poly(N-vinylpyrrolidone), or TA/PVPON. The layers are formed around a sacrificial core that is dissolved after the layers are complete. In the current research, the chelator DFO was covalently linked to the PVPON, and the capsules were composed of alternating layers of TA and PVPON-DFO, for a total of six or 12 bilayers.

Lapi is professor of radiology and vice chair of Translational Research, and she is the director of the UAB Cyclotron Facility, which produces both clinical and investigational radionuclides. Lapi also directs the Radiochemistry Laboratory and the Division of Advanced Medical Imaging Research.

The UAB researchers found that (TA/PVPON-DFO) six-bilayer capsules retained, on average, 17 percent more zirconium-89 than their (TA/PVPON) counterparts, evidence that linking DFO to PVPON provides stable chelation. In vivo PET imaging of mice showed excellent stability and imaging contrast that was still present seven days post-injection. The capsules accumulated primarily in the spleen, liver and lungs, and there was negligible accumulation in the femur. Since the femur is the site where free zirconium-89 accumulates, this lack of accumulation in the femur confirmed stable binding of the radiotracer to the capsule. Finally, applying therapeutic levels of ultrasound to the zirconium-functionalized capsules released the anticancer drug doxorubicin -- loaded inside the microcapsules -- in therapeutic amounts.

Thus, the microcapsules overcome three limitations seen in the majority of current PET-guided theranostic agents: 1) poor retention of radiometal over time, 2) low drug-loading capacities, and 3) time-limited PET imaging capability.
Co-first authors of the study, "Multilayer microcapsules with shell-chelated 89Zr for PET imaging and controlled delivery," published in the journal ACS Applied Materials & Interfaces, were Veronika Kozlovskaya, Ph.D., and Aaron Alford, Ph.D., UAB Department of Chemistry.

Other co-authors with Kharlampieva, Lapi, Kozlovskaya and Alford are Maksim Dolmat and Racquel Caviedes, UAB Department of Chemistry; and Maxwell Ducharme and Lauren Radford, UAB Department of Radiology.

Support came from National Science Foundation Division of Materials Research award 1608728 and National Science Foundation Major Research Instrumentation Program award 1828232. Imaging studies were also supported through the O'Neal Comprehensive Cancer Center at UAB grant P30CA013148.

University of Alabama at Birmingham

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.